So far, this has been demonstrated in the context of neuroblastoma, against which Vγ9Vδ2+ T cells have minimal innate cytotoxicity (37), in part due to the tumor shedding soluble NKG2D ligands which block NKG2D activation (97, 98). This evidence concerns the gene KLRK1 and neuroblastoma.